Combining spironolactone to antiretroviral therapy accelerates HIV decay in humanized mice
Spironolactone (SP), a clinically used aldosterone antagonist, has been explored as an anti-HIV agent in models of HIV-1 latency for inducing transcriptional silencing of the viral reservoir. SP promotes the degradation of xeroderma pigmentosum group B (XPB) protein, a crucial component of transcrip...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2025-12-01
|
| Serier: | Emerging Microbes and Infections |
| Fag: | |
| Online adgang: | https://www.tandfonline.com/doi/10.1080/22221751.2025.2589549 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
